Number of applicants matched to each discipline grouped by (a) clinical disciplines, (b) diagnostic disciplines, and (c) surgical disciplines. by Lucy Hui (17538542)

DataSheet1_Pharmacological inhibition of receptor protein tyrosine phosphatase β/ζ decreases Aβ plaques and neuroinflammation in the hippocampus of APP/PS1 mice.docx by Teresa Fontán-Baselga (20392470)

“…In addition, we observed a significant decrease in the number and size of astrocytes in both sexes and in the number of microglial cells in a sex-dependent manner. …”

Cyclosporin A significantly reduces the survival rate and completely inhibits the formation of multicellular aggregates in tolerant strains under caspofungin stress. by Yongqin Wu (272012)

Supplementary Material for: Longitudinal Decrease in Left Ventricular Size with Age: Impact on Mortality and Cardiovascular Hospitalization by figshare admin karger (2628495)

“…Results: A decrease in LVEDD was observed in 24% of participants (mean change -9±3 mm) and was significantly associated with older age, female sex, decreased volumes, concentric remodeling and diastolic dysfunction. …”

Demographic and clinical data at baseline. by Karel Joineau (21799908)

Subjects:

Between the PCSO-524 group and the placebo group unpaired comparisons of the change between visits of quality of life and respiratory variables scores. by Nattapon Riengvirodkij (11268720)

Subjects:

Table 1_Group B Streptococcus vaginal colonisation throughout pregnancy is associated with decreased Lactobacillus crispatus and increased Lactobacillus iners abundance in the vagi... by Toby I. Maidment (15296219)

Comparing demographic and clinical characteristics of patients before and COVID-19 outbreak. by Mahsa Motiei (18275525)

Subjects:

ONSD modifications induced by arterial paCO₂ changes. by Marco Carbonara (11483575)

Subjects:

Change in maternal characteristics during 2003–2017, HSJ and control. by Eva Rydahl (6260771)

Subjects:

Analysis of the correlation between LDHA expression and clinical characteristics. by Siyu Yuan (7425719)

Subjects:

Image 2_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg by David Qixiang Chen (8198265)

“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Image 1_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg by David Qixiang Chen (8198265)

“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Each square gives extinction probability p (AB) or median population change d (CD) for 100 simulations at . by Alexandra M. Campbell (3284094)

Subjects:

Analysis of Significantly Different Bacteria. by Xu Jia (187142)

Clinical data of the control and CoA cases in our cohort. by Inmaculada Villanueva-Baxarias (21454246)

Subjects:

Lipid Droplet-Targeted NIR Polarity Probe for the Imaging of Acute Asthma <i>In Vivo</i> by Mingyue Li (1582399)

Subjects:

Data Sheet 1_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx by David Qixiang Chen (8198265)

“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Data Sheet 2_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx by David Qixiang Chen (8198265)

“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Data Sheet 3_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx by David Qixiang Chen (8198265)

“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”